{"database": "lobbying", "table": "lobbying_activities", "rows": [[2769373, "75a5dcf9-bbed-44b6-a6a0-dd4596c8a13a", "Q1", "FRANCIS EDWARD & CRONIN, INC.", 311314, "CURE ALZHEIMER'S FUND", 2022, "first_quarter", "MED", "Issues and legislation related to Alzheimer's disease research", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE", 0, 0, "2022-04-01T08:52:55-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2769373"], "units": {}, "query_ms": 0.5099409900140017, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}